For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
FIT tests and biopsies: Bringing bowel cancer prevention to the masses
+In the spotlight
In print
Feature
FIT tests and biopsies: Bringing bowel cancer prevention to the masses
Wednesday 4 October 2017, 05:02 PM
Residents in Hutt Valley and Wairapapa, aged 60 and 74, will soon be opening their letterbox to find information about the National Bowel Screening Programme
After five years of trialling and planning, New Zealand starts to see bowel screening introduced to the wider population this month. General practice is crucial to the success of the programme. Virginia McMillan finds out what it means for practices and their older patients
Far from being struck down with anxiety about the “C” word, most patients appreciate the call from their GP or practice nurse informing them of a posi, John McMenamin and Susan Parry, John McMenamin, GP lead for the National Bowel Screening Programme, with Susan Parry, clinical director of the bowel cancer team at the Ministry of He
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.